- Home
- JOB vs ESLA Comparison
JOB vs ESLA Comparison
Compare JOB & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JOB
- ESLA
- Stock Information
- Founded
- JOB 1893
- ESLA 2021
- Country
- JOB United States
- ESLA United States
- Employees
- JOB N/A
- ESLA N/A
- Industry
- JOB Diversified Commercial Services
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JOB Consumer Discretionary
- ESLA Health Care
- Exchange
- JOB Nasdaq
- ESLA Nasdaq
- Market Cap
- JOB 28.3M
- ESLA 41.6M
- IPO Year
- JOB N/A
- ESLA N/A
- Fundamental
- Price
- JOB $0.26
- ESLA $0.82
- Analyst Decision
- JOB
- ESLA
- Analyst Count
- JOB 0
- ESLA 0
- Target Price
- JOB N/A
- ESLA N/A
- AVG Volume (30 Days)
- JOB 181.3K
- ESLA 370.5K
- Earning Date
- JOB 12-16-2024
- ESLA 11-01-2024
- Dividend Yield
- JOB N/A
- ESLA N/A
- EPS Growth
- JOB N/A
- ESLA N/A
- EPS
- JOB N/A
- ESLA N/A
- Revenue
- JOB $122,402,000.00
- ESLA N/A
- Revenue This Year
- JOB N/A
- ESLA N/A
- Revenue Next Year
- JOB $18.60
- ESLA N/A
- P/E Ratio
- JOB N/A
- ESLA N/A
- Revenue Growth
- JOB N/A
- ESLA N/A
- 52 Week Low
- JOB $0.23
- ESLA $0.77
- 52 Week High
- JOB $0.59
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- JOB 51.80
- ESLA 39.62
- Support Level
- JOB $0.25
- ESLA $0.87
- Resistance Level
- JOB $0.27
- ESLA $1.24
- Average True Range (ATR)
- JOB 0.01
- ESLA 0.12
- MACD
- JOB 0.00
- ESLA -0.01
- Stochastic Oscillator
- JOB 58.50
- ESLA 12.57
About JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.